ATE403423T1 - Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln - Google Patents

Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln

Info

Publication number
ATE403423T1
ATE403423T1 AT02706082T AT02706082T ATE403423T1 AT E403423 T1 ATE403423 T1 AT E403423T1 AT 02706082 T AT02706082 T AT 02706082T AT 02706082 T AT02706082 T AT 02706082T AT E403423 T1 ATE403423 T1 AT E403423T1
Authority
AT
Austria
Prior art keywords
cholesterol levels
ldl cholesterol
drugs including
lowering ldl
including pravastatin
Prior art date
Application number
AT02706082T
Other languages
English (en)
Inventor
Rene Belder
Mark E Mcgovern
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE403423T1 publication Critical patent/ATE403423T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02706082T 2001-02-27 2002-01-28 Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln ATE403423T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/794,449 US20020183383A1 (en) 2001-02-27 2001-02-27 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE403423T1 true ATE403423T1 (de) 2008-08-15

Family

ID=25162649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02706082T ATE403423T1 (de) 2001-02-27 2002-01-28 Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln

Country Status (9)

Country Link
US (2) US20020183383A1 (de)
EP (1) EP1377277B1 (de)
AR (1) AR033424A1 (de)
AT (1) ATE403423T1 (de)
DE (1) DE60228064D1 (de)
ES (1) ES2309148T3 (de)
PE (1) PE20020893A1 (de)
UY (1) UY27187A1 (de)
WO (1) WO2002067911A1 (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5622985A (en) * 1990-06-11 1997-04-22 Bristol-Myers Squibb Company Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
GB2253787A (en) * 1991-01-28 1992-09-23 Merck & Co Inc Hypercholesterolemia treating compositions
US6369103B1 (en) * 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
IL149422A0 (en) * 1999-11-03 2002-11-10 Smith Howard J & Ass Pty Ltd Oral pharmaceutical compositions for liver therapy

Also Published As

Publication number Publication date
EP1377277A1 (de) 2004-01-07
WO2002067911A1 (en) 2002-09-06
US20020183383A1 (en) 2002-12-05
AR033424A1 (es) 2003-12-17
US20030125379A1 (en) 2003-07-03
PE20020893A1 (es) 2002-10-25
DE60228064D1 (de) 2008-09-18
UY27187A1 (es) 2002-09-30
EP1377277B1 (de) 2008-08-06
ES2309148T3 (es) 2008-12-16

Similar Documents

Publication Publication Date Title
AU2003298825A8 (en) Innovations for the display of web pages
EE200000574A (et) Farmatseutilised ühendid angiogeensete häirete kuvamiseks
NO20035609D0 (no) Fremgangsmåte for kontinuerlig naftabehandling
DK1412328T3 (da) Dolastatin-10-derivater
HU0100388D0 (en) Pharmaceutical compositions and methods for treating osteoporosis and lowering cholesterol
HK1095733A1 (en) Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis
DE60227765D1 (de) Plasmabildschirm
DE60212268D1 (de) Schrank zum Befördern von Medizin
DE60226581D1 (de) Anzeigeeinheit und ansteuerverfahren dafür
AU2002307208A1 (en) Multi-provider funeral plan web site and administration thereof
DE60045332D1 (de) Öl-in-wasser emulsion
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
IL159153A0 (en) Methods for testing drugs for treating or preventing diseases such as hyperlipidemia
AU2002309083A1 (en) Method for identifying drugs for the treatment of type ii diabetes
AU2002353659A1 (en) Simvastatin dosage forms
ATE403423T1 (de) Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln
AU2002333276A1 (en) Drugs for vasculopaties
DK1225890T3 (da) Rivastigmin til behandling af öjensygdomme
AU2001253233A1 (en) Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia
DE60200770D1 (de) Plasmabildschirm und Ansteuerverfahren dafür
HK1050316A1 (zh) 膽固醇降低劑
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
PT102547A (pt) Recinto modular para preparacoes estereis
AU2002304733A1 (en) Amino-aza-cyclohexanes for the treatment of malaria
AU2003280285A8 (en) Gucy1b2 genetic markers for ldl cholesterol response to statin therapy

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties